Thursday, 17th January 2019

 Virology and Microbiology

              New strategies for prevention and control of viral diseases: foot-and-mouth disease
              virus as a model




Francisco Sobrino




Research summary:

Foot-and-mouth disease virus (FMDV) is one of the major concerns for animal health. It is also an interesting model system for understanding the interactions of a highly variable virus and its natural hosts and the implications of these interactions on disease control. We are working in the development of new FMDV marker vaccines that can induce protective humoral and cellular immune responses, using the pig, an important natural host, as an animal model. Some of these strategies are also being applied to the development of new vaccines against classical swine fever (CSF).

fig01-300  -------  fig02-300
Diagram showing a FMDV pentameric capsid subunit, including mutations that increase (red) or reduce (blue) the acidic pH sensitivity of viral particle. VP1 green, VP2 magenta, VP3 cian.  

Structural model for the dimer established between the N-ter of two FMDV 3A proteins. Residues participating in the hydrophobic interface, whose contribution to dimer stability has been experimentally tested, are indicated.



We are also analyzing the functional role of FMDV proteins on the internalization, the replication cycle and the mechanisms mediating the pathogenesis of FMDV and other related viruses causing vesicular diseases, such as swine vesicular disease virus (SVDV), and vesicular stomatitis virus (VSV) in cultured cells and in animal models. Special attention is being paid to the functional implications of non-structural proteins, like those from the FMDV 3AB region, in virus virulence and host range. A parallel study of the functional implications of non-coding RNA regions is also being conducted, in particular their capacity to elicit innate immune responses and their potential use as antiviral and immunomodulatory elements after delivery as synthetic RNA transcripts. Besides providing basic information on the multiplication cycle of these viruses, the results obtained are being used for the identification of antiviral targets, attenuation determinants as well as the design of new vaccine strategies. As part of these studies, we are characterizing the inhibitory effect of valproic acid on the multiplication of enveloped viruses.oltura.

Relevant publications:

  • Vázquez-Calvo, A., Saiz, J.C., Sobrino, F*. and Martín-Acebes, M.A. Inhibition of enveloped virus infection of cultured cells by valproic acid. J. Virol. 85, 1267-1274 (2011).
  • Tarradas, J., Monsó, M., Muñoz, M., Rosel, R., Fraile, L., Mora, M., Muñoz, I., Andreu, D., Sobrino, F. and Ganges, L.* Partial protection against classical swine fever virus elicited by dendrimeric vaccine-candidate peptide in domestic pigs. Vaccine 29, 4422-4429 (2011).
  • Martín-Acebes, M., Vázquez-Calvo, A, Rincón, V., Mateu; M.G. and Sobrino, F*. A single amino acid substitution in the capsid of foot-and-mouth disease virus can increase acid resistance. J. Virol. 85, 2733-2740 (2011)
  • Rodríguez-Pulido, M., Borrego, B., Sobrino, F. and Sáiz, M*. RNA structural domains in non-coding regions of foot-and-mouth disease virus genome trigger innate immunity in porcine cells and mice. J. Virol. 85, 6492-6501 (2011).
  • Rodríguez-Pulido, M., Sobrino, F., Borrego, B. and Sáiz. M*. Inoculation of newborn mice with non-coding regions of foot-and-mouth disease virus RNA can induce a rapid, solid and wide-range protection against viral infection. Antiviral Res. 92, 500-504 (2011).
  • González-Magaldi, M., Postigo, R., de la Torre, B.G., Vieira, Y.A., López-Viñas, E., Gómez-Puertas, P., Andreu, D., Kremer, L., Rosas, M. F. and Sobrino, F*. Mutations that hamper dimerization of foot-and-mouth disease virus 3A protein are detrimental for infectivity. J. Virol. 86, 11013-11023 (2012).
  • Vázquez-Calvo,A., Caridi, F., Rodriguez-Pulido, M., Borrego, B., Sáiz, F, Sobrino, F*. and Martín-Acebes, M.A. Modulation of foot-and-mouth disease virus pH threshold for uncoating correlates with differential sensitivity to inhibition of cellular Rab GTPases and decreases infectivity in vivo. J. Gen. Virol. 93:2382-2386 (2012).
  • Vázquez-Calvo, A., Sobrino, F*. and Martín-Acebes. M.A. Plasma membrane phosphatidylinositol 4, 5 bisphosphate is required for internalization of foot-and-mouth disease virus and vesicular stomatitis virus. PLoS ONE, 7(9): e45172. doi:10.1371/journal.pone.0045172 (2012). Rodríguez-Pulido, M., Martín-Acebes, M-A.,
  • Escribano-Romero, E., Blázquez A.B., Sobrino, F., Borrego, B., Sáiz, M., Saiz, J.C.* Protection against West Nile virus infection in mice after inoculation with type I interferon-inducing RNA transcripts. PLoS ONE 7(11): e49494 (2012).
  • Borrego, B., Rodríguez-Pulido, B., Mateos, F., de la Losa, N., Sobrino, F. and Sáiz*, M. Delivery of synthetic RNA can enhance the immunogenicity of vaccines against foot-and-mouth disease virus (FMDV) in mice. Vaccine. 40, 4375-4381 (2013).
  • Sanchez-Aparicio, M.T., Rosas, M.F. and Sobrino, F*. Characterization of a nuclear localization signal in the foot-and-mouth disease virus polymerase. Virology 444, 203-210 (2013).
  • Blanco, E., Cubillos, C., Moreno, N., Bárcena, J., de la Torre, B.G., Andreu and Sobrino, F*. B epitope multiplicity/ and B/T epitope orientation influence immunogenicity of foot-and-mouth disease peptide vaccines. Clin. Dev. Immunol. 2013:475960 (2013).
  • Vazquez-Calvo, A. Caridi, F. Sobrino*, F. and Martín-Acebes, M.A. An increase in acid resistance of foot-and-mouth disease virus capsid is mediated by a tyrosine substitution of the VP2 histidine previously associated with VP0 cleavage. J. Virol. 88, 3039-3042 (2014).
  • Martín-Acebes, M.A., Merino-Ramos, T., Blázquez, A-B., Casas, J., Escribano-Romero, E., Sobrino, F*. and Saiz, J.C*. The Composition of West Nile virus Lipid Envelope Unveils a Role of Sphingolipid Metabolism on Flavivirus Biogenesis J. Virol. 88(20), 12041-54 (2014).
  • González-Magaldi, M., Martín-Acebes, M., Kremer, L. and Sobrino, F*. Membrane topology and cellular dynamics of foot-and-mouth disease virus 3A protein. PLoS ONE. 9(10): e106685. (2014).
  • Caridi, F., Vázquez-Calvo, A., Sobrino, F*. and Martín-Acebes, M.A. The pH stability of foot-and-mouth disease virus particles is modulated by residues Located at the pentameric interface and in the N terminus of VP3. J. Virol. (2015).
  • Borrego, B., Rodríguez-Pulido, M., Revilla, C., Álvarez, B., Sobrino F., Domínguez, J. and Sáiz, M*. Synthetic RNAs mimicking structural domains in the foot-and-mouth disease virus (FMDV) genome elicit a broad innate immune response in porcine cells triggered by RIG-I and TLR activation. Viruses 7, 3954-3973. doi:10.3390/v7072807 (2015).
  • Martin-Acebes, M.A., Gabandé-Rodríguez, E., García-Cabrero, A.M., Sánchez, M.P., Ledesma, M.D., Sobrino, F*. and Saiz, J.C.* Host Sphingomyelin Modulates West Nile Virus Infection in vivo. J. Lipid. Res. 57, 422-32. doi: 10.1194/jlr.M064212 (2016).
  • Blanco E.*, Guerra, G., de la Torre, B.G., Defaus, S., Andreu, D*. and Sobrino, F*. Full protection of swine against foot-and-mouth disease challenge by a bivalent B-cell epitope dendrimer peptide. Antiviral Res. 129, 74-80. doi: 10.1016/j.antiviral.2016.03.005 (2016).
  • The amino acid substitution Q65H in the 2C protein of swine vesicular disease virus confers resistance to Golgi disrupting drugs. Vázquez-Calvo, A., Caridi, F., González-Magaldi, M., Saiz, J.C. Sobrino, F*. and Martín-Acebes, M.A.*. Frontiers Microbiol. 7:612. doi: 10.3389/fmicb.2016.00612 (2016).

* Corresponding author



  1. M. Sáiz, F. Sobrino, B. Borrego, M. Rodriguez, J.C. Sáiz y M.A Martín. Uso de una región no codificante del genoma del virus de la fiebre aftosa para la elaboración de un medicamento antiviral.P201130445. España (25 de marzo 2011). PCT solicitada el 25/3/2012 (PCT ES 2012/070198). CSIC-INIA.
  2. C. Cubillo, E. Blanco, J. Bárcena, F. Sobrino y D. Andreu. Peptide vaccines for the prevention of foot-and-mouth disease. P8244EP00. Patente Europea (2 de marzo de 2012). UPF, CSIC, INIA.

Doctoral Theses:

Mónica González Magaldi (2012). Caracterización de la proteína 3A del virus de la fiebre aftosa. Estudio de su dimerización, capacidad de unión a membranas y dinámica celular. Director: F. sobrino.

Angela Vázquez Calvo (2012). Estudio de los requerimientos para la entrada del virus de la fiebre aftosa en cultivos celulares y caracterización de ácido valproico como compuesto antiviral. Universidad Autónoma de Madrid. Directores: M.A. Martín Acebes y F. Sobrino (CBMSO).

Yuri A. Vieira (2015).  Contribuciones  al estudio de la funcionalidad de las proteínas no estructurales del virus de la fiebre aftosa. Universidad Autónoma de  Madrid. Directores: M.F. Rosas y F. Sobrino.

NOTE! This site uses cookies and similar technologies.

If you not change browser settings, you agree to it. Learn more

I understand


What are cookies?

A cookie is a file that is downloaded to your computer when you access certain web pages. Cookies allow a web page, among other things, to store and retrieve information about the browsing habits of a user or their equipment and, depending on the information they contain and the way they use their equipment, they can be used to recognize the user.

Types of cookies

Classification of cookies is made according to a series of categories. However, it is necessary to take into account that the same cookie can be included in more than one category.

  1. Cookies according to the entity that manages them

    Depending on the entity that manages the computer or domain from which the cookies are sent and treat the data obtained, we can distinguish:

    • Own cookies: those that are sent to the user's terminal equipment from a computer or domain managed by the editor itself and from which the service requested by the user is provided.
    • Third party cookies: those that are sent to the user's terminal equipment from a computer or domain that is not managed by the publisher, but by another entity that processes the data obtained through the cookies. When cookies are installed from a computer or domain managed by the publisher itself, but the information collected through them is managed by a third party, they cannot be considered as own cookies.

  2. Cookies according to the period of time they remain activated

    Depending on the length of time that they remain activated in the terminal equipment, we can distinguish:

    • Session cookies: type of cookies designed to collect and store data while the user accesses a web page. They are usually used to store information that only is kept to provide the service requested by the user on a single occasion (e.g. a list of products purchased).
    • Persistent cookies: type of cookies in which the data is still stored in the terminal and can be accessed and processed during a period defined by the person responsible for the cookie, which can range from a few minutes to several years.

  3. Cookies according to their purpose

    Depending on the purpose for which the data obtained through cookies are processed, we can distinguish between:

    • Technical cookies: those that allow the user to navigate through a web page, platform or application and the use of different options or services that exist in it, such as controlling traffic and data communication, identifying the session, access to restricted access parts, remember the elements that make up an order, perform the purchase process of an order, make a registration or participation in an event, use security elements during navigation, store content for the broadcast videos or sound or share content through social networks.
    • Personalization cookies: those that allow the user to access the service with some predefined general characteristics based on a series of criteria in the user's terminal, such as the language, the type of browser through which the user accesses the service, the regional configuration from where you access the service, etc.
    • Analytical cookies: those that allow the person responsible for them to monitor and analyse the behaviour of the users of the websites to which they are linked. The information collected through this type of cookies is used in the measurement of the activity of the websites, applications or platforms, and for the elaboration of navigation profiles of the users of said sites, applications and platforms, in order to introduce improvements in the analysis of the data of use made by the users of the service.

Cookies used on our website

The CBMSO website uses Google Analytics. Google Analytics is a simple and easy to use tool that helps website owners to measure how users interact with the content of the site. You can consult more information about the cookies used by Google Analitycs in this link.

Acceptance of the Cookies Policy

The CBMSO assumes that you accept the use of cookies if you continue browsing, considering that it is a conscious and positive action from which the user's consent is inferred. In this regard, you are previously informed that such behaviour will be interpreted that you accept the installation and use of cookies.

Knowing this information, it is possible to carry out the following actions:

How to modify the configuration of cookies

Using your browser you can restrict, block or delete cookies from any web page. In each browser the process is different, here we show you links on this particular of the most used browsers: